AI Model Could Help With Difficult Pediatric Genetic Diagnosis

In this episode of Science Snapshot, see how Boston Children’s Hospital used OpenAI’s o3 Deep Research model to surface leads in 18 previously unsolved pediatric cases.

Science Snapshot logo with a black faded background representing electronic wires.

Genetic sequencing is more widely available than ever, giving clinicians a wealth of genetic information at their disposal—but the real challenge can be pinpointing the disease-causing variant among millions of harmless ones. A new study shows how OpenAI’s o3 Deep Research model was used as an evidence-sifting assistant to help surface leads for 18 previously unsolved pediatric cases. 

So where does AI help most, and where do humans have to take over?

Watch the full video to learn how the team at Boston Children’s Hospital took a new approach to finding answers.

Explore Related Courses

AI in Medicine: Unlocking Precision Medicine through Omics and AI

Learn how omics and AI are transforming the path to precision medicine.

  • HMX Online Learning
  • Online; Self-Paced
  • Start Today
  • Group Enrollment Option

Dates: Available Anytime

For: Clinicians and health care professionals; biomedical researchers; and professionals in managerial roles

AI in Medicine: Foundations and Applications in Medical Practice and Research

Explore the foundational principles of artificial intelligence (AI) and its transformative applications in medicine and biomedical research.

  • HMX Online Learning
  • Online; Self-Paced
  • Start Today
  • Group Enrollment Option

Dates: Available Anytime

For: Clinicians and health care professionals; researchers in biomedicine and technology sectors; and professionals a across health care fields

Genetic Testing and Sequencing Technologies

Explore recent advances in genetic testing and learn about the implications for patient care.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option
  • Registration Deadline Approaching:

Dates: -

For: Clinicians and other medical professionals; researchers in biomedicine and industry sectors; professionals in biotechnology and health care-related fields